North America Enteral Nutrition Market

The North America enteral nutrition market was valued at US$ 3,206.58 million in 2022 and is expected to reach US$ 5,187.48 million by 2030; it is estimated to grow at a CAGR of 6.2% from 2022 to 2030.

Increasing Prevalence of Gastrointestinal Diseases Fuel North America Enteral Nutrition Market

Gastrointestinal diseases include Crohn's disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancer types. As per the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019; the US (762,890) had the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Crohn's disease is a complex, chronic disorder primarily affecting the digestive system. Moreover, short bowel syndrome (SBS) occurs in ~3 per 1 million people yearly. As per the article titled "Understanding Short Bowel Syndrome: Current Status and Future Perspectives," published in 2020, the prevalence of SBS has increased by more than twofold in the last 40 years. The prevalence of SBS was ~300 cases per 10 million in the US.

Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They may also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirements, which can be a result of the disease itself. Thus, medical nutrition is recommended for these patients due to their inability to ingest food. Enteral routes are preferred to provide them with essential nutrients. Enteral feeding refers to the direct intake of food nutrients through the mouth or through a tube that passes the digestive tract (mouth to stomach/small intestine and then anus). This type of nutrition is preferred to provide treatment support for patients suffering from chronic ailments, such as neurological disorders, gastrointestinal diseases, and inherited metabolic diseases. Therefore, the surging prevalence of gastrointestinal diseases drives the growth of the enteral nutrition market.

North America Enteral Nutrition Market Overview

The North America enteral nutrition market is segmented into the US, Canada, and Mexico. North America accounts for a significant market share owing to the rising prevalence of chronic diseases, growing strategic developments by market players, and increasing preference for enteral nutrition contribute to the market progress in this region. Moreover, an upsurge in knowledge among individuals about the benefits of medical nutrition, such as tube feeding, in the treatment of chronic health conditions are anticipated to boost the North America enteral nutrition market growth during the forecast period.

Chronic diseases, such as cancer and heart disease, are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country have at least one chronic disease. Additionally, the American Hospital Association estimates ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children.

North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

North America Enteral Nutrition Market Segmentation

The North America enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.

Based on product type, the North America enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger North America enteral nutrition market share in 2022.

In terms of application, the North America enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest North America enteral nutrition market share in 2022.

Based on age group, the North America enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger North America enteral nutrition market share in 2022.

By distribution channel, the North America enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest North America enteral nutrition market share in 2022.

Based on country, the North America enteral nutrition market is categorized into the US, Canada, and Mexico. The US dominated the North America enteral nutrition market in 2022.

Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Dr Schar AG, Reckitt Benckiser Group Plc, Nutritional Medicinals LLC, Kate Farms Inc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd are some of the leading companies operating in the North America enteral nutrition market.

North America Enteral Nutrition Market Strategic Insights

North America Enteral Nutrition Market Segmentation Analysis

North America Enteral Nutrition Market Report Highlights

North America Enteral Nutrition Report Scope

North America Enteral Nutrition Market Country and Regional Insights